A BioPharm International cover story draws on the perspectives of industry experts, taking a modality-by-modality approach to recognizing the unique challenges in developing non-traditional biologics.
Joseph Jeong, EVP and Head of R&D, expands on the role of evolving regulatory guidelines for developing emerging modalities, as well as on strategies for manufacturing ADCs.
A BioPharm International cover story draws on the perspectives of industry experts, taking a modality-by-modality approach to recognizing the unique challenges in developing non-traditional biologics.
Joseph Jeong, EVP and Head of R&D, expands on the role of evolving regulatory guidelines for developing emerging modalities, as well as on strategies for manufacturing ADCs.
Share article
Related Content